HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreThe Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) is requesting comments regarding questions that explore allowing nurse practitioners and physician assistants to be eligible to take the NIOSH B Reader examination to become certified B Readers.
B Readers classify chest radiographic images of workers exposed to coal mine dust, crystalline silica, or asbestos for pneumoconiosis surveillance programs, such as the NIOSH Coal Workers' Health Surveillance Program. Currently, only physicians licensed to practice in the United States who have passed the examination can become certified B Readers. The examination was developed by NIOSH and the American College of Radiology® (ACR®) to test physicians’ ability to apply the International Labour Organization (ILO) classification system to chest radiographs.
ACR intends to file comments in response to NIOSH’s questions. To provide input for ACR’s consideration, contact Michael Peters, ACR Senior Director, Government Affairs. To provide public comments directly to NIOSH, carefully review the agency’s questions and provide feedback online.
HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreACR Weighs in on NRC Standard General License Proposal
ACR supports easing NRC licensing burdens but urges limits on new SGL use, ensuring existing training standards and clarity within broader regulatory reforms.
Read moreDr. Pisano Highlights ACR AI Leadership and Builds International Connections
Etta Pisano urged global collaboration on safe, effective medical AI and highlighted ACR programs advancing AI standards and clinical trial innovation.
Read more